Purpose: Current strategies to create small-diameter vascular grafts involve seeding biocompatible, compliant scaffolds with autologous vascular cells. Our purpose was to study the composition and strength of decellularized vein to determine its potential as a vascular tissue-engineering scaffold. Methods: Intact human greater saphenous vein specimens were decellularized by using sodium dodecyl sulfate (SDS). Residual cellular and extracellular matrix composition was studied with light and electron microscopy as well as immunohistochemistry. Burst and suture-holding strength was measured in vitro by insufflation and pull-through techniques. To assess initial handling and durability of decellularized vein in vivo, a canine model was developed wherein decellularized canine jugular veins were implanted as carotid interposition grafts in recipient animals. After two weeks of arterial perfusion, these grafts were studied with duplex imaging and histologic methods. 
Autologous vascular tissue remains the standard for small-diameter (Ͻ6-mm) arterial bypass. For patients who lack this tissue vital for successful surgery, the currently available prosthetic, biologic, and allograft alternatives are less than satisfactory. Early tissue-engineering strategies to solve this problem involved seeding nonabsorbable prosthetic grafts with vascular cells. 1, 2 Although these conduits have shown promise, they have not achieved widespread clinical acceptance. More recent techniques involve seeding of biocompatible, compliant scaffolds with vascular cells. Examples include tubes made of collagen, biodegradable polymers, and xenograft arterial tissue rendered acellular by using aldehyde fixation or other various cell extraction methods. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] These innovative paradigms are well studied, but remain challenged with issues such as adequate initial strength, cell viability following polymer degradation, immunologic incompatibility, and long-term aneurysm formation.
The present study investigates an alternative scaffold for vascular tissue engineering. This scaffold is created by treating human saphenous vein derived from transplant tissue donors with a detergent (sodium dodecyl sulfate [SDS] ) to remove its cells, thereby decreasing its antigenicity. The use of human vein as a tissue source for vascular scaffold creation has not been well described in the literature. Potential advantages to its use include ready availability, ease of procurement from transplant tissue donors, and the avoidance of significant immunogenic issues associated with xenograft tissues. Furthermore, the use of SDS to decellularize venous tissue has not been previously reported. Possible advantages to its use include preservation of extracellular matrix important for strength and cell attachment, and avoidance of problems associated with aldehyde-fixed tissues (poor graft compliance and aneurysmal degeneration).
Of all these potential advantages, the most important characteristic of this or any new vascular conduit is ade-quate initial strength. This absolute requirement avoids the devastating complications of acute rupture and anastomotic degeneration. Herein, we investigate the composition and structure of SDS-decellularized vein and test the hypothesis that it retains the structural integrity necessary to withstand arterial implantation.
MATERIAL AND METHODS
This study was conducted under protocols approved by Thomas Jefferson University's Institutional Review Board and Institutional Animal Care and Use Committee. The animal care complied with the Guide for the Care and Use of Laboratory Animals. Table I summarizes the materials and methods used in this study.
Vein preparation. Human greater saphenous vein (GSV), taken from all segments of the lower extremity, was obtained fresh from patients undergoing vascular surgical procedures. To avoid bias based on vein caliber or location, only specimens long enough to be cut into adjacent control and experimental samples were used. The nondistended segments were transported to the laboratory in Medium 199 (Gibco BRL, Grand Island, NY) at 4°C. Decellularization was performed by placing the specimens in SDS (Sigma Chemical Company, St. Louis, Mo) in a 37 o C shaking water bath for 15 hours. The veins were subsequently washed with agitation 5 times in phosphate-buffered saline (PBS) for periods of 10 minutes each. To determine the minimal concentration of SDS necessary to achieve decellularization, concentrations of 0.01, 0.025, 0.05, 0.075, and 0.1% SDS in PBS were tested. Controls included untreated freshly harvested vein, as well as vein processed similar to treated veins but without SDS (0.0% SDS).
Determination of cellularity. One-cm vein segments were fixed in 10% formalin, paraffin embedded, transversely sectioned (5 m) at their midpoints, and stained with hematoxylin-eosin. By using a light microscope interfaced with an image analysis system (Phase 3 Imaging System and Spot RT true color digital camera), all nuclei in the intima, media and adventitia present within a 0.025-mm bandwidth were counted. Four quadrants in 4 transverse sections (total of 16 counts) were averaged for each fresh control (n ϭ 10) and decellularized (n ϭ 10) specimen. % decellularization ϭ [cell count for fresh vein Ϫ cell count for decellularized vein] Ϭ cell count for fresh vein ϫ 100%.
Vein submitted for scanning electron microscopy was fixed overnight by using 2.5% glutaraldehyde in cacodylate buffer at 4 o C. Samples were then post-fixed in 1% OsO 4 , and dehydrated with graded ethanol. The specimens were then critical-point dried, opened longitudinally, mounted lumen side up, and sputter-coated with gold. Specimens were then viewed using a JEOL 840 scanning electron microscope. The luminal surface of 4 fresh control and 4 decellularized (0.075% SDS) veins were examined qualitatively for the presence of endothelial cells (ECs).
Evaluation of extracellular matrix. Collagen and elastin morphology was analyzed, using methods similar to Har-Shai et al. 16 Vein samples were fixed in 10% formalin, paraffin embedded, sectioned transversely (5 m) and double-stained by using the Verhoff-vonGieson method. Using a light microscope interfaced with a digital image analysis system, the area occupied by both collagen (red) and elastin (black) fibers 17 per high-powered field (hpf ϭ 40ϫ magnification) was measured. Twenty areas in 4 transverse sections (total of 80 hpf) were averaged for each fresh control (n ϭ 10) and decellularized (n ϭ 10) specimen. Percent fiber ϭ [average fiber area per hpf] ϫ 100%.
Basement membrane was evaluated by using immunohistochemistry. Paraffin-embedded blocks containing vein specimens fixed in 10% formalin were deparaffinized and rehydrated in ethanol followed by water. After blocking sections with H 2 O 2 , mouse IgG monoclonal antibody against the 7S domain of human type IV collagen (Chemicon, Temecula, Calif) was applied and incubated for 1 hour using a 1:5,000 dilution. The immune complexes were then visualized by light microscopy following application of Dako Liquid DABϩ Substrate-Chromogen Solution (DakoCytomation, Carpinteria, Calif) and counterstaining 18 For burst strength, vein specimens (2.5 cm) were cannulated proximally, filled with PBS, and occluded distally with a silk tie. Intraluminal pressure was increased by 300mm Hg/s using an ACS Indeflator Plus 20 pressure gauge until vein rupture. Burst strength was recorded in mm Hg for both fresh control (n ϭ 10) and decellularized (n ϭ 10) specimens.
Suture-holding strength was measured by using a spring-loaded tensiometer. Polypropylene sutures (5-0) were placed in 4 quadrants 1 mm from the vessel edge. Increasing linear pressure was increased by 50gm/s until the suture pulled through the vein edge. Eight measurements (4 values taken from both ends of the vein sample) were averaged for fresh control (n ϭ 10) and decellularized (n ϭ 10) veins, and recorded in grams.
Assessment of graft durability in vivo. To evaluate the strength of decellularized vein in vivo, a canine vein graft model mimicking human arterial bypass grafting was developed. Preliminary experiments identical to those used to determine the cellularity of human vein after SDS treatment were performed with canine external jugular vein. Transmural cell removal was again near complete using 0.075% SDS.
Using 1-year-old, 25-to 30-kg female mongrel dogs (n ϭ 8), 16 external jugular vein grafts were harvested and prepared as follows: (1) autografts (n ϭ 8) were immediately placed back into the donor animal, (2) allografts (n ϭ 4) were immediately transplanted into a recipient animal, and (3) decellularized allografts (n ϭ 4) underwent cell extraction by using 0.075% SDS prior to transplantation into a recipient animal. These veins were implanted bilaterally as carotid interposition grafts as follows: after heparinization (3000 U), the vein grafts (4 cm) were reversed, spatulated, and sutured using 7-0 polypropylene, with excision of the intervening carotid artery. Each animal received a fresh autograft plus either a fresh allograft or decellularized allograft on the contralateral side. Electronic calipers were used to measure midgraft diameter immediately following reperfusion. The heparin was reversed with protamine, and the animal was recovered. No aspirin was administered.
At two weeks, all grafts underwent transcutaneous duplex Doppler ultrasound examination using high frequency linear array transducers (Siemens Medical Systems, Acuson Sequoia 512) to assess patency, dilation (largest graft diameter was measured in mm) and anastomotic false aneurysm formation. The grafts were subsequently explanted under general anesthesia. The carotid arteries were cannulated proximally and distally to the interposition graft and perfusion-fixed with 500 cc of 10% buffered formalin at 100 mm Hg over 30 minutes. The grafts were explanted en bloc, fixed for an additional 24 hours, and sectioned. The sections were paraffin embedded, hematoxylin-eosin stained, and examined with light microscopy.
Statistical analysis. All data are reported as average value Ϯ standard deviation. Paired, two-tailed Student t tests were performed to determine if the cell counts, fiber areas, and burst and suture-holding strengths were statistically different (P Ͻ .05) between the groups tested.
RESULTS

Decellularization of vein by SDS is nearly complete.
Both light (Fig 1) and scanning electron (Fig 2) microscopy revealed that the luminal surface of human GSV is completely devoid of endothelial cells following treatment with SDS. This was observed at all concentrations of SDS tested (0.01%-0.1%). Examination of transverse vein sections further revealed that SDS removed cells resident within the vein wall. Table II shows quantification of cell extraction for the entire vessel wall versus SDS concentration used. Cell removal was significant for all treatment groups (P Ͻ .001) and was concentration-related, with near total decellularization (Ͼ94%) occurring at SDS concentrations Ն0.075%. As decellularization was essentially complete following 0.075% SDS treatment, this concentration was used for all further morphologic and strength studies.
Extracellular matrix structure is preserved following decellularization. Light microscopy (Fig 3) of fresh and SDS-treated vein stained with the Verhoff-vonGieson method revealed gross preservation of extracellular matrix collagen and elastin fibers. Digital image analysis of fresh and decellularized specimens (Fig 4) suggested that collagen fiber area remained stable (45.8% Ϯ 4.6% vs 41.5% Ϯ 7.3%; P Ͼ .05) and elastin fiber area decreased only slightly (10.4 Ϯ4.8 vs 8.3% Ϯ 3.8%; P ϭ .02). Values represent the mean Ϯ SD (n ϭ 10). SDS, Sodium dodecyl sulfate. *P Ͻ .001 compared with fresh vein.
Immunohistochemical staining of collagen Type IV (Fig 5) , the major component of vascular basement membrane, revealed preservation of this protein after SDS cellular extraction. Qualitatively, a dense layer of collagen IV is seen along the luminal surface and within the vessel wall of both the fresh and SDS-treated veins.
Decellularized vein is mechanically strong. In vitro study revealed that burst (2480 Ϯ 470 vs 2380 Ϯ 620 mm Hg, respectively; P Ͼ .05) and suture-holding (185 Ϯ 30 vs 178 Ϯ 66 gm; P Ͼ .05) strength was not significantly altered following cellular extraction with 0.075% SDS (Fig  6) . Grossly, decellularized vein appeared pale, with other- Decellularized vein remains stable following implantation into the arterial system. In vivo canine experiments revealed that decellularized vein grafts had operative handling characteristics indistinguishable from fresh vein grafts. Intraoperative hemostasis was achieved with equal success in both decellularized and fresh vein groups.
All animals survived surgery and the 2 weeks following implantation without neurologic, infectious, or hemorrhagic complication. All grafts remained patent by both duplex and pathologic examination. No significant graft dilation (Table III) , rupture or anastomotic false aneurysm was documented during the period of arterial perfusion.
DISCUSSION
This study represents our initial efforts to tissue engineer a small-diameter bypass graft. Similar to other engineering paradigms, our ultimate goal is to develop an "off-the-shelf" conduit-scaffold that subsequently can be seeded with autologous vascular cells prior to implantation. We chose human GSV as the tissue source for such a product. In practice, this vein would be harvested from transplant tissue donors, decellularized to reduce antigenic- ity, and cryopreserved to make it readily available for future seeding and use.
In these beginning investigations, we developed a technique for decellularizing venous tissue using SDS, a common tissue detergent. Using the minimal SDS concentration necessary to render vein acellular, we subsequently demonstrated retention of extracellular matrix morphology and strength. Together, these studies serve as proof of concept for the use of decellularized vein as potential a conduit-scaffold for vascular tissue engineering.
Although many recent vascular tissue engineering strategies use artery as a tissue source, use of human saphenous vein offers several potential advantages: (1) ease of harvest from transplant tissue donors, (2) length and diameter appropriate for bypass procedures, (3) a thin vascular wall that is easy to decellularize, and (4) a thinner matrix that allows for migration of autologous recipient cells and improved luminal inspissation of nutrients. Of note, several investigators use xenograft vascular sources for ready availability. Use of allograft tissue, however, avoids various infection issues as well as the known propensity for xenograft vascular tissue to degenerate into aneurysm. 19, 20 Decellularization is a technique used to decrease antigenicity, thereby reducing subsequent graft rejection and host allosensitization. There are several methods to remove cells from tissue; these include hypotonic cell lysis, enzymatic digestion, mechanical stripping, and tissue fixation. SDS is a tissue detergent that lyses cell membranes, and is one of many such detergents. We have chosen SDS for study because of its (1) ease of use, (2) success in a published model of vascular tissue decellularization, 19, 20 and (3) ability to lyse cells uniformly within all layers of the tissue. Furthermore, its mechanism of action may make it less damaging than other enzymatic, mechanical, or tissue fixation methods. A major goal of this study is to examine the effect of SDS on venous tissue, a process unreported in the literature.
Decellularization with SDS resulted in uniform cell removal throughout the tissue. Complete endothelial cell removal was not surprising, even for the lowest SDS concentrations, as their loss is also promoted by tissue hypoxia and mechanical shaking. Removal of the smooth muscle cells required higher concentrations of SDS, and appeared dose-related.
Examination of the extracellular matrix and basement membrane demonstrated that SDS did not significantly alter morphology. This finding is important as collagen is responsible for vessel strength, and elastin imparts distensibility and recoil. 21 Additionally, as type IV collagen contains ligands important for firm endothelial cell attachment and retention, basement membrane preservation may be key to foster the future repopulation of these grafts with vascular cells. 22 Adequate initial strength is an absolute requirement for any arterial bypass graft. A primary goal of this study was to determine the strength of SDS-treated vein and its feasibility as a vascular conduit. Results of the in vitro strength tests (burst and suture pull-through) suggest that SDS decellularization did not significantly alter vein strength. From a functional standpoint, this finding corroborates our findings that no significant change was found in collagen morphology.
To further substantiate these in vitro findings, we developed an in vivo canine model that mimics the use of decellularized vein in humans. In this model, canine external jugular vein was used as a tissue source for decellularized vein grafts. By preserving this allogenic relationship between the donor grafts and recipients, we avoided the immunologic issues with xenograft transplantation. These in vivo studies demonstrated excellent handling characteristics of decellularized vein grafts and their ability to withstand arterial pressure without vascular complication over a 2-week period. Combined with the in vitro studies, these results provide the strongest proof of concept and safety for the potential use of decellularized vein as a bypass graft.
In addition to conduit strength, an equally important characteristic of arterial bypass is maintenance of patency. The in vivo model used in this study (a high-flow, largediameter site) was chosen because it tests the graft's ability to withstand arterial pressure without the confounding factor of thrombosis. 23 As such, we cannot draw significant conclusion about this important characteristic. Given the pivotal role endothelial cells play in maintaining patency under low-flow conditions, we suspect decellularized vein would not perform equally to autologous tissues in these circumstances. Luminal seeding of the graft with autologous endothelial cells prior to implantation is now the subject of ongoing studies.
Study limitations. The mainstay of our structural analysis was digital image analysis following histochemical staining. Although our methods suggest stable extracellular matrix fiber morphology, quantitative molecular analysis of collagen and elastin was not performed to assay structural changes within the fibers themselves. Similarly, although our techniques to measure in vitro and in vivo strength and handling provided reliable data consistent with values found in the literature for fresh saphenous vein, 18 they may not be definitive predictors of long-term durability. This latter characteristic is dependent upon many factors, including extracellular matrix production and turnover. Fi- Initial graft diameter measured by calipers immediately after reperfusion at time of implantation; 2-week diameter is based on surface duplex measurement; values represent mean Ϯ SD (n ϭ 8 for group 1; n ϭ 4 for both groups 2 and 3).
nally, the in vivo durability of decellularized human saphenous vein cannot directly be assured by the results of our animal model. Because we chose to use canine vein as the tissue source for our grafts, thereby avoiding the confounding immunogenic issues of putting human vein directly into the model, the structural differences between human saphenous vein and canine jugular vein weakens our conclusions.
SUMMARY
These data suggest that vein decellularized by using SDS represents a potential scaffold for further vascular tissue engineering efforts. Cell extraction by using SDS is simple and near complete, without significant disturbance of the extracellular matrix and basement membrane morphology. Excellent strength was demonstrated in both in vitro and in vivo studies, attesting to the preservation of its basic extracellular matrix structure.
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